Kir Kahlon · activist-deck
Nevro Corp. (NVRO)
239 pages · 3 arc beats · 2 loops
Nevro Corp. (NVRO)
Kir Kahlon · 2021-01 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
1102030405060708090100110120130140150160170180190200210220230239
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 142 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
The Monster 12 slides 100% 12/12 slides 100% 12/12 slides · 95 hits — 0/12 slides
66.7% 8/12 slides · 10 hits 66.7% 8/12 slides 100% 12/12 slides 91.7% 11/12 slides The Struggle 30 slides 100% 30/30 slides 100% 30/30 slides · 232 hits — 0/30 slides
13.3% 4/30 slides 80% 24/30 slides · 25 hits 100% 30/30 slides 3.3% 1/30 slides The Victory 100 slides 100% 100/100 slides 100% 100/100 slides · 940 hits — 0/100 slides
9% 9/100 slides · 13 hits 72% 72/100 slides · 73 hits 100% 100/100 slides 10% 10/100 slides Slide inventory
239 every slide · same image gating as the playbook
01
Includes a YouTube link referencing the film 'Spinal Tap' as a metaphor for the company's technology.front_matter
03
The slide uses yellow highlighting to emphasize the most damaging claims within the quotes.expose_contradiction
04
The slide uses a series of quotes to build a narrative of corporate malfeasance and product failure.expose_contradiction
05
The TOC includes aggressive, thesis-driven descriptions for each section, typical of activist short reports.front_matter
06
The slide uses aggressive, highly critical language to frame the upcoming sections of the report.summarize
07
This is a continuation of a larger table of contents, starting at item 13.summarize
08
This slide appears to be a continuation of a larger table of contents, starting at page 18.summarize
09
The slide uses highly critical, emotive language ('medieval', 'crude', 'Hail Mary') to frame the company's core product negatively.frame_problem
Open slide detailBeat · The Monster
10
The slide uses a 'villain' framing by highlighting the '180 degree unwind' of the company's core messaging and patient complaints about charging.frame_problem
11
The slide uses a combination of narrative text, a testimonial quote, and a bar chart to link high-volume implanters to high payments.name_villain
12
The slide uses a strong, accusatory tone, labeling the company a 'textbook Ponzi'.diagnose_problem
13
Includes a stock chart of Nuvectra and quotes from former executives/KOLs to support the thesis.name_villain
14
The slide highlights Nevro's underperformance compared to its peers in the top 50 medtech companies by market cap.compare_peers
15
The slide uses a dual-axis chart to show revenue growth vs. YOY growth rate, illustrating the 'hitting a wall' narrative.diagnose_problem
16
The slide uses a red circle to highlight a specific claim from a company presentation, which the activist is likely about to debunk.expose_contradiction
17
The slide uses a 'villain critique' style to frame management's excuses as implausible, setting up the investigative methodology.expose_contradiction
18
The slide uses a testimonial-heavy format to undermine the company's official narrative regarding sales force attrition and product performance.expose_contradiction
19
The slide uses highlighted text to emphasize negative performance metrics reported by former consultants and KOLs.expose_contradiction
20
The slide uses direct quotes from KOLs to build a narrative of corporate dishonesty and product failure.expose_contradiction
21
The slide uses anecdotal evidence from a 'longtime executive' to frame Nevro as deceptive.expose_contradiction
Open slide detailBeat · The Struggle
22
Uses heavy use of yellow highlighting for emphasis on critical quotes.expose_contradiction
Open slide detailBeat · The Struggle
23
The slide uses yellow highlighting to emphasize critical claims about the CEO's lack of engagement and the company's underlying performance issues.expose_contradiction
Open slide detailBeat · The Struggle
24
The slide uses historical revenue data from two previous companies to discredit the CEO's reputation as a turnaround specialist.expose_contradiction
Open slide detailBeat · The Struggle
25
Uses a 'villain' narrative to undermine the credibility of the current CEO by linking him to a past corporate scandal.expose_contradiction
Open slide detailBeat · The Struggle
26
Uses emotional appeal and external media (Netflix documentary, NYT review) to frame the subject as a villain.name_villain
Open slide detailBeat · The Struggle
27
The slide uses a 'villain' framing by associating the company with the opioid crisis and the Insys fentanyl scandal.name_villain
Open slide detailBeat · The Struggle
28
The slide uses a 'villain critique' approach by citing external authorities to undermine the company's product efficacy and business ethics.expose_contradiction
Open slide detailBeat · The Struggle
29
Uses a pull-quote from a surgical nurse to emphasize the negative patient experience.expose_contradiction
Open slide detailBeat · The Struggle
30
The slide uses expert quotes to undermine the company's clinical claims.name_villain
Open slide detailBeat · The Struggle
31
The slide uses a 'three-point' narrative structure to build a case against the company's safety record.expose_contradiction
Open slide detailBeat · The Struggle
32
The slide uses aggressive language ('smoke and mirrors', 'criminal', 'big scam') to frame the company as a bad actor.name_villain
Open slide detailBeat · The Struggle
33
The slide uses highlighted text to emphasize specific claims about tolerance and pathological changes.name_villain
Open slide detailBeat · The Struggle
34
Uses social proof/anecdotal evidence to undermine company claims of safety.expose_contradiction
Open slide detailBeat · The Struggle
35
The slide uses direct quotes from social media to build a case against the product's efficacy and patient experience.illustrate_case
Open slide detailBeat · The Struggle
36
The slide uses a 'villain' framing technique by aggregating negative user experiences to undermine the company's product claims.expose_contradiction
Open slide detailBeat · The Struggle
37
Uses graphic imagery and patient testimonials to frame the company's product as dangerous and the medical practice as profit-driven.name_villain
Open slide detailBeat · The Struggle
38
The slide uses anecdotal evidence (patient social media posts) to frame the company's product as a 'hustle' or 'quackery'.expose_contradiction
Open slide detailBeat · The Struggle
39
The slide uses screenshots of Facebook posts to build a narrative of corporate negligence and product failure.expose_contradiction
Open slide detailBeat · The Struggle
40
The slide uses anecdotal evidence from Facebook support groups to build a negative narrative about the company's product performance.illustrate_case
Open slide detailBeat · The Struggle
41
The slide uses a combination of analyst commentary and a direct testimonial to frame the company as a 'one-trick pony' in decline.summarize
Open slide detailBeat · The Struggle
42
The slide uses strong, accusatory language typical of activist short reports.summarize
Open slide detailBeat · The Struggle
43
The slide uses a strong 'expose contradiction' narrative, contrasting company claims with KOL interviews and clinical studies.expose_contradiction
Open slide detailBeat · The Struggle
44
This slide is part of an activist short report, focusing on product failure and management deception.summarize
Open slide detailBeat · The Struggle
45
This is an activist short-seller report slide. It uses anecdotal evidence from KOLs to build a narrative of systemic failure.summarize
Open slide detailBeat · The Struggle
46
This slide uses strong, accusatory language typical of activist short-seller reports to frame the company's culture and market position.summarize
Open slide detailBeat · The Struggle
47
This slide uses qualitative evidence from KOLs and ex-employees to build a narrative of corporate failure.summarize
Open slide detailBeat · The Struggle
48
The slide uses strong, aggressive language to discredit the company's product claims and growth strategy.expose_contradiction
Open slide detailBeat · The Struggle
49
This is a text-heavy slide summarizing negative findings from expert interviews (KOLs and former executives).summarize
Open slide detailBeat · The Struggle
50
The slide uses anecdotal evidence from former executives to build a bearish case against Nevro's turnaround and acquisition potential.summarize
51
This slide uses aggressive, activist-style language to frame Nevro as a failing company and Saluda as a disruptive competitor.summarize
52
The slide uses strong, accusatory language typical of activist short reports to frame the company's business model as fundamentally broken.diagnose_problem
53
The slide uses strong, accusatory language to frame the company's business model as legally compromised.expose_contradiction
54
This is a classic activist short-seller slide designed to frame the company's business model as inherently fraudulent and legally precarious.diagnose_problem
55
This slide focuses on the legal/ethical risk of reps performing clinical duties.expose_contradiction
56
The slide uses yellow highlighting to emphasize the specific claims being challenged.expose_contradiction
57
The slide uses a combination of academic citation and visual data to frame the study as potentially fraudulent.expose_contradiction
58
Uses excerpts from a press release and a clinical paper to highlight study design flaws.expose_contradiction
59
The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.expose_contradiction
60
Uses direct quotes to undermine the credibility of the company's primary clinical evidence.expose_contradiction
61
The slide uses highlighted text to emphasize key accusations regarding the validity of the 10kHz frequency and the integrity of the clinical trial data.expose_contradiction
Open slide detailBeat · The Victory
62
Uses red circles to highlight specific names and study titles to draw attention to the contradiction.expose_contradiction
Open slide detailBeat · The Victory
63
The slide uses yellow highlighting to emphasize key accusations of trial manipulation.expose_contradiction
Open slide detailBeat · The Victory
64
The slide uses highlighted text to emphasize key accusations of study manipulation and corruption.expose_contradiction
Open slide detailBeat · The Victory
65
The slide uses anecdotal evidence from public review sites to attack the character of a key study investigator.name_villain
Open slide detailBeat · The Victory
66
The slide uses a series of pull-quotes to build a narrative of fraud, specifically highlighting the 'cherry-picking' of patients to skew study results.expose_contradiction
Open slide detailBeat · The Victory
67
The slide uses testimonials from former executives to build a case of fraud against the company's clinical trial methodology.expose_contradiction
Open slide detailBeat · The Victory
68
The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.expose_contradiction
Open slide detailBeat · The Victory
69
The slide uses highlighted text to emphasize key accusations of data manipulation and criminal behavior.expose_contradiction
Open slide detailBeat · The Victory
70
Uses highlighted text to emphasize critical claims from experts.expose_contradiction
Open slide detailBeat · The Victory
71
Uses highlighted quotes to build a case against the company's core technology claims.expose_contradiction
Open slide detailBeat · The Victory
72
The slide highlights a specific clinical study (PROCO) to undermine the competitive advantage of the subject company's core technology.expose_contradiction
Open slide detailBeat · The Victory
73
The slide uses testimonials to undermine the company's core product claim.expose_contradiction
Open slide detailBeat · The Victory
74
Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.expose_contradiction
Open slide detailBeat · The Victory
75
The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.expose_contradiction
Open slide detailBeat · The Victory
76
Uses testimonials to undermine the company's core value proposition.expose_contradiction
Open slide detailBeat · The Victory
77
The slide uses highlighted text to emphasize key pain points regarding battery life and charging frequency.name_villain
Open slide detailBeat · The Victory
78
Uses direct quotes from company filings and website to frame the 'paresthesia-free' claim as a vulnerability.expose_contradiction
Open slide detailBeat · The Victory
79
Uses testimonials to contradict the company's marketing claims.expose_contradiction
Open slide detailBeat · The Victory
80
Uses expert testimony to frame the company's core technology as a liability.name_villain
Open slide detailBeat · The Victory
81
The slide uses a testimonial to frame the company's core product feature as a business liability.expose_contradiction
Open slide detailBeat · The Victory
82
The slide uses expert testimony to undermine the company's core value proposition.name_villain
Open slide detailBeat · The Victory
83
The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.name_villain
Open slide detailBeat · The Victory
84
The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.expose_contradiction
Open slide detailBeat · The Victory
85
The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claimsexpose_contradiction
Open slide detailBeat · The Victory
86
The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.expose_contradiction
Open slide detailBeat · The Victory
87
The slide uses a series of quotes from KOLs (Key Opinion Leaders) to build a narrative of systemic failure and industry skepticism.expose_contradiction
Open slide detailBeat · The Victory
88
The slide uses direct quotes from a KOL to frame the company's behavior as unethical and retaliatory.expose_contradiction
Open slide detailBeat · The Victory
89
Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.expose_contradiction
Open slide detailBeat · The Victory
90
The slide uses testimonials to build a narrative of industry-wide dissatisfaction and lack of transparency regarding explant data.expose_contradiction
Open slide detailBeat · The Victory
91
The slide uses highlighted quotes to emphasize the severity of the alleged device failures and the high volume of Nevro patients requiring salvage therapy.expose_contradiction
Open slide detailBeat · The Victory
92
Uses highlighted quotes to emphasize negative feedback from medical professionals.expose_contradiction
Open slide detailBeat · The Victory
93
Uses expert testimony to challenge official company data.expose_contradiction
Open slide detailBeat · The Victory
94
Uses testimonial-style quotes from competitor employees to undermine company disclosures.expose_contradiction
Open slide detailBeat · The Victory
95
The slide uses a 'case study' format to provide qualitative evidence of product failure.illustrate_case
Open slide detailBeat · The Victory
96
The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.illustrate_case
Open slide detailBeat · The Victory
98
The slide uses highlighted text to emphasize critical data points regarding patient satisfaction and explant rates.illustrate_case
Open slide detailBeat · The Victory
99
The slide uses highlighted text to emphasize key allegations of fraud and data manipulation.expose_contradiction
Open slide detailBeat · The Victory
100
The slide uses a 'case study' format to expose product failure and corporate ethics issues.illustrate_case
Open slide detailBeat · The Victory
101
The slide uses highlighted text to emphasize critical claims about medical device safety and physiological impact.name_villain
Open slide detailBeat · The Victory
102
The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.illustrate_case
Open slide detailBeat · The Victory
103
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.illustrate_case
Open slide detailBeat · The Victory
104
The slide uses highlighted text to emphasize critical quotes from a medical professional.illustrate_case
Open slide detailBeat · The Victory
105
The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.illustrate_case
Open slide detailBeat · The Victory
106
The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.expose_contradiction
Open slide detailBeat · The Victory
107
The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.expose_contradiction
Open slide detailBeat · The Victory
108
The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.expose_contradiction
Open slide detailBeat · The Victory
109
The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.expose_contradiction
Open slide detailBeat · The Victory
110
The slide uses a direct quote to frame the company's behavior as deceptive.expose_contradiction
Open slide detailBeat · The Victory
111
The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.expose_contradiction
Open slide detailBeat · The Victory
112
The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.expose_contradiction
Open slide detailBeat · The Victory
113
The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insyexpose_contradiction
Open slide detailBeat · The Victory
114
Uses a 'gotcha' interview format to frame the company's business model as deceptive.expose_contradiction
Open slide detailBeat · The Victory
115
Uses testimonial evidence from KOLs to support the claim of corporate deception.expose_contradiction
Open slide detailBeat · The Victory
116
The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.expose_contradiction
Open slide detailBeat · The Victory
117
Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.expose_contradiction
Open slide detailBeat · The Victory
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.expose_contradiction
Open slide detailBeat · The Victory
119
The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.expose_contradiction
Open slide detailBeat · The Victory
120
Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.name_villain
Open slide detailBeat · The Victory
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.expose_contradiction
Open slide detailBeat · The Victory
122
Uses direct quotes to undermine the company's value proposition.expose_contradiction
Open slide detailBeat · The Victory
123
The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.expose_contradiction
Open slide detailBeat · The Victory
124
The slide uses highlighted text to emphasize key claims about market share loss and device failure.expose_contradiction
Open slide detailBeat · The Victory
125
The slide uses expert testimony to undermine the company's market position and stock performance.expose_contradiction
Open slide detailBeat · The Victory
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.expose_contradiction
Open slide detailBeat · The Victory
127
The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.expose_contradiction
Open slide detailBeat · The Victory
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.expose_contradiction
Open slide detailBeat · The Victory
129
The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.expose_contradiction
Open slide detailBeat · The Victory
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.expose_contradiction
Open slide detailBeat · The Victory
131
Uses direct quotes from the company's own SEC filings to highlight hypocrisy.expose_contradiction
Open slide detailBeat · The Victory
132
Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.expose_contradiction
Open slide detailBeat · The Victory
133
Uses CEO quote to undermine management credibility.expose_contradiction
Open slide detailBeat · The Victory
134
Uses testimonial quotes to undermine company narrative.expose_contradiction
Open slide detailBeat · The Victory
135
Uses authority-citation framework to undermine the company's product launch.name_villain
Open slide detailBeat · The Victory
136
Uses highlighted quotes to emphasize negative sentiment from industry experts.name_villain
Open slide detailBeat · The Victory
137
Uses expert quotes to undermine the company's product strategy.expose_contradiction
Open slide detailBeat · The Victory
138
Uses direct quotes from KOLs to undermine the company's product launch narrative.expose_contradiction
Open slide detailBeat · The Victory
139
The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.name_villain
Open slide detailBeat · The Victory
140
Uses expert testimony to undermine company narrative regarding product success.expose_contradiction
Open slide detailBeat · The Victory
141
The slide uses direct quotes from former employees to undermine the company's product strategy.expose_contradiction
Open slide detailBeat · The Victory
142
Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.illustrate_case
Open slide detailBeat · The Victory
143
Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.name_villain
Open slide detailBeat · The Victory
144
Uses quotes from KOLs and former users to frame the company as a 'one-trick pony' facing inevitable decline.name_villain
Open slide detailBeat · The Victory
145
The slide uses expert quotes to frame the company's strategic pivot as a sign of desperation and loss of identity.name_villain
Open slide detailBeat · The Victory
146
Uses yellow highlighting to emphasize key claims of deception.expose_contradiction
Open slide detailBeat · The Victory
147
Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.expose_contradiction
Open slide detailBeat · The Victory
148
Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.expose_contradiction
Open slide detailBeat · The Victory
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.expose_contradiction
Open slide detailBeat · The Victory
150
Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.expose_contradiction
Open slide detailBeat · The Victory
151
Uses expert quotes to undermine the company's core product claims.expose_contradiction
152
Uses KOL testimonials to highlight a technical contradiction in the company's product claims.expose_contradiction
153
Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.expose_contradiction
154
Uses direct quotes from KOLs to undermine company narrative.expose_contradiction
155
The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.expose_contradiction
156
The slide uses historical data to undermine the company's 'innovation' narrative.expose_contradiction
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.expose_contradiction
158
Uses a series of quotes to undermine the company's growth narrative.expose_contradiction
159
Uses expert quotes to undermine the company's growth narrative.expose_contradiction
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.expose_contradiction
161
The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.expose_contradiction
162
The slide uses expert testimony to undermine the credibility of the company's clinical research and growth narrative.name_villain
163
Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.expose_contradiction
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.expose_contradiction
165
Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.expose_contradiction
166
The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.name_villain
167
Uses multiple KOL quotes to undermine the company's growth narrative.expose_contradiction
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.expose_contradiction
169
Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.name_villain
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.expose_contradiction
171
Uses expert testimony to contradict company growth narratives.expose_contradiction
172
Uses a direct quote from a KOL to undermine the company's growth thesis.expose_contradiction
173
Uses expert testimonials to debunk company growth narrative.expose_contradiction
174
Features highlighted text blocks in yellow to emphasize critical quotes from former executives.name_villain
176
Uses expert testimony to undermine management credibility and highlight operational failures.expose_contradiction
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.expose_contradiction
178
Uses expert testimony to undermine the investment thesis of a turnaround.expose_contradiction
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.expose_contradiction
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.expose_contradiction
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.expose_contradiction
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.preempt_rebuttal
183
Uses expert testimony to debunk market optimism regarding M&A.expose_contradiction
184
The slide uses expert testimony to debunk the bull case of a potential acquisition.preempt_rebuttal
185
The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.expose_contradiction
186
The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinicaname_villain
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.expose_contradiction
188
The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.name_villain
189
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.expose_contradiction
190
The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.expose_contradiction
191
The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.name_villain
193
Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.expose_contradiction
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.expose_contradiction
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.expose_contradiction
196
Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.expose_contradiction
197
The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.expose_contradiction
198
The slide uses a 'villain critique' approach by framing the company's growth story as 'false' and 'misguided' while citing external regulatory bodies to validatname_villain
199
The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.expose_contradiction
200
Uses highlighted text to emphasize key negative sentiment from KOLs.expose_contradiction
201
Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.expose_contradiction
202
Uses direct quotes from high-volume implanters to contradict the market growth narrative.expose_contradiction
203
The slide uses a series of testimonials to undermine the company's growth narrative.expose_contradiction
204
The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.expose_contradiction
205
The slide uses expert testimony to debunk the company's growth claims.expose_contradiction
206
Includes a direct testimonial from a high-volume implanter to support the thesis.expose_contradiction
207
The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.expose_contradiction
208
Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.expose_contradiction
209
The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.expose_contradiction
210
Uses yellow highlighting to emphasize key incriminating phrases in the quotes.expose_contradiction
211
The slide uses a combination of a trend line chart, a summary table of payment types, and a detailed table of specific recipient payments to build a case of finexpose_contradiction
212
Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.expose_contradiction
213
Uses a screenshot of an official government document to frame the company's business model as fraudulent.expose_contradiction
214
Uses yellow highlighting to emphasize key incriminating phrases in quotes.expose_contradiction
215
Uses yellow highlighting to emphasize key incriminating phrases in the quotes.expose_contradiction
216
The slide uses a series of quotes to build a narrative of corruption and unethical business practices.expose_contradiction
217
The slide uses highlighted text to emphasize key allegations of illegal payments and the prioritization of financial incentives over clinical evidence.expose_contradiction
218
The slide uses inflammatory language ('cesspool', 'exploitation') to frame the company as a villain.name_villain
219
The slide uses the 'ceo-quote-contradiction' framework to frame the CEO's own words as evidence of unethical business practices.expose_contradiction
220
Uses testimonial-style quotes to frame the company as corrupt and exploitative.name_villain
221
The slide uses a 'villain critique' approach by framing the company's business model as exploitative and unsustainable.name_villain
222
Uses testimonial evidence to frame the company's sales practices as unethical and exploitative.expose_contradiction
223
The slide uses testimonial quotes to frame the company's business model as exploitative.expose_contradiction
224
Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.expose_contradiction
225
The slide uses direct quotes from KOLs to frame the sales representatives as unethical actors.name_villain
226
Uses direct quotes from KOLs (Key Opinion Leaders) to build a case of unethical business practices.name_villain
227
Uses testimonials from former executives and KOLs to support the thesis of financial abuse.expose_contradiction
228
Uses KOL (Key Opinion Leader) quotes to frame the company's business model as exploitative.expose_contradiction
229
Uses direct quotes from former employees to build a case of unethical business practices.expose_contradiction
230
Uses testimonial evidence to frame the company's business model as unethical.expose_contradiction
231
The slide uses quotes from KOLs and executives to frame the company's revenue model as exploitative.expose_contradiction
232
The slide uses testimonials to frame the company's business model as predatory.expose_contradiction
233
Uses direct quotes from high-volume implanters to substantiate claims of systemic abuse in specific US regions.expose_contradiction
234
The slide uses a 'villain critique' approach by framing the company's core operational model as a criminal liability.expose_contradiction
235
The slide uses direct quotes from KOLs and high-volume implanters to build a case for regulatory/legal risk regarding the unauthorized practice of medicine.expose_contradiction
236
Uses a quote from a former executive to support the claim of unauthorized medical practice.expose_contradiction
237
The slide uses a screenshot of a social media post as primary evidence to support the claim of unauthorized practice of medicine.expose_contradiction
238
Uses direct quotes from former executives to build a case of regulatory and ethical risk.expose_contradiction
239
The slide uses a direct quote from a KOL to support the thesis that Nevro reps are overstepping their professional boundaries.expose_contradiction